Phagos
Phagos develops an AI-native phage therapy platform called Alphagos to design targeted bacterial treatments using bacteriophages. The company combines microbiology and artificial intelligence to create treatments that address antimicrobial resistance in the livestock and aquaculture industries. Their solutions are currently deployed across the chicken, cattle, swine, and shrimp sectors.
Visit websiteSuresnes, France
Healthtech
Biotechnology
AgTech
Artificial Intelligence
Funding summary
- Total raised
- €27.4M
- Funding rounds
- 2
Investors in Phagos
Investors on record for Phagos. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Phagos?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors